跳至主要内容
临床试验/JPRN-jRCT1051190043
JPRN-jRCT1051190043招募中2 期

Safety and efficacy of Budesonide administration after endoscopic balloon dilation for Crohn's disease patients with intestinal stenosis - OGF1707

Takehara Tetsuo0 个研究点目标入组 15 人开始时间: 2019年9月2日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Mild to moderate active Crohn's disease patients with written consent at Osaka University Hospital and affiliated hospitals, who have intestinal stenosis and are scheduled or recieved endoscopic balloon dilation (EBD), are included.

排除标准

  • Patients with more than 5 centimeters long stenosis
  • Patients with internal or external fistula
  • Patients with active infection, including abscess
  • Patients with oral treatment of antithrombotic drugs or low platelet that counts less than 50000 per microlitter
  • Patients with cancer
  • Patients under 20 years old
  • Patients with severy bad general condition
  • Patients who are administered steroids within 4 weeks
  • Patients who are judged inapropriate by doctors

研究者

发起方
Takehara Tetsuo

相似试验